{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:31:00Z","timestamp":1789173060121,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s11864-004-0038-y","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T08:42:06Z","timestamp":1183020126000},"page":"499-509","source":"Crossref","is-referenced-by-count":36,"title":["Meningioma: Current treatment options and future directions"],"prefix":"10.1007","volume":"5","author":[{"given":"Kevin P.","family":"McMullen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker W.","family":"Stieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"38_CR1","first-page":"324","volume-title":"Textbook of Radiation Oncology: Principles","author":"BJ Goldsmith","year":"1998","unstructured":"Goldsmith BJ: Meningioma. In Textbook of Radiation Oncology: Principles, edn 1. Edited by Leibel SJ, Phillips TI. New York: Elsevier; 1998: 324\u2013340.","edition":"edn 1."},{"key":"38_CR2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3171\/jns.2004.100.6.1002","volume":"100","author":"O Al Mefty","year":"2004","unstructured":"Al Mefty O, Topsakal C, Pravdenkova S, et al.: Radiationinduced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics. J Neurosurg 2004, 100:1002\u20131013.","journal-title":"J Neurosurg"},{"key":"38_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1158\/1078-0432.CCR-0938-3","volume":"10","author":"B Asgharian","year":"2004","unstructured":"Asgharian B, Chen YJ, Patronas NJ, et al.: Meningiomas may be a component tumor of multiple endocrine neoplasia type 1. Clin Cancer Res 2004, 10:869\u2013880.","journal-title":"Clin Cancer Res"},{"key":"38_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0889-8588(05)70268-9","volume":"15","author":"A Kimmelman","year":"2001","unstructured":"Kimmelman A, Liang BC: Familial neurogenic tumor syndromes. Hematol Oncol Clin North Am 2001, 15:1073\u20131084.","journal-title":"Hematol Oncol Clin North Am"},{"key":"38_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0090-3019(89)90201-2","volume":"32","author":"MS Eljamel","year":"1989","unstructured":"Eljamel MS, Foy PM: Multiple meningiomas and their relation to neurofibromatosis review of the literature and report of seven cases. Surg Neurol 1989, 32:131\u2013136.","journal-title":"Surg Neurol"},{"key":"38_CR6","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","volume":"21","author":"A Perry","year":"1997","unstructured":"Perry A, Stafford SL, Scheithauer BW, et al.: Meningioma grading: an analysis of histologic parameters: seminal paper on the histopathology of meningioma. Am J Surg Pathol 1997, 21:1455\u20131465. Seminal paper on the histopathology of meningioma.","journal-title":"Am J Surg Pathol"},{"key":"38_CR7","unstructured":"International Agency for Research on Cancer: World Health Organization Classification of Tumours: Pathology and Genetics: Tumours of the Nervous System, edn 2. United Kingdom; Oxford Univ Press: 2000. Standard reference work on the histopathology of central nervous system malignancies."},{"key":"38_CR8","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry A, Scheithauer BW, Stafford SL, et al.: Malignancy in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999, 85:2046\u20132056. Seminal paper on the grading of malignant meningiomas.","journal-title":"Cancer"},{"key":"38_CR9","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jocn.2004.03.001","volume":"11","author":"JD Laidlaw","year":"2004","unstructured":"Laidlaw JD, Kumar A, Chan A: Dural metastases mimicking meningioma [case review]. J Clin Neurosci 2004, 11:780\u2013783.","journal-title":"J Clin Neurosci"},{"key":"38_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00234-004-1194-2","volume":"46","author":"S Kremer","year":"2004","unstructured":"Kremer S, Grand S, Remy C, et al.: Contribution of dynamic contrast magnetic resonance imaging to the differentiation between dural metastasis and meningioma. Neuroradiology 2004, 46:642\u2013648.","journal-title":"Neuroradiology"},{"key":"38_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/A:1014404918118","volume":"56","author":"FM Verheijen","year":"2002","unstructured":"Verheijen FM, Donker GH, Viera CS, et al.: Progesterone receptor, bc1-2, and bax expression in meningiomas. J Neurooncol 2002, 56:35\u201341.","journal-title":"J Neurooncol"},{"key":"38_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/713605429","volume":"6","author":"M Wahab","year":"2003","unstructured":"Wahab M, Al Azzawi F: Meningioma and hormonal influences. Climacteric 2003, 6:285\u2013292.","journal-title":"Climacteric"},{"issue":"Suppl 1","key":"38_CR13","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.maturitas.2003.09.021","volume":"46","author":"CJ Gruber","year":"2003","unstructured":"Gruber CJ, Huber JC: Differential effects of progestins on the brain. Maturitas 2003, 46(Suppl 1):S71-S75.","journal-title":"Maturitas"},{"key":"38_CR14","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1212\/01.WNL.0000118300.82017.F4","volume":"62","author":"MC Chamberlain","year":"2004","unstructured":"Chamberlain MC, Tsao-Wei DD, Groshen S: Temozolomide for treatment-resistant recurrent meningioma. Neurology 2004, 62:1210\u20131212.","journal-title":"Neurology"},{"key":"38_CR15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1023\/A:1026770624783","volume":"49","author":"HB Newton","year":"2000","unstructured":"Newton HB, Slivka MA, Stevens C: Hydroxyurea chemotherapy for unresectable or residual meningioma. J Neurooncol 2000, 49:165\u2013170.","journal-title":"J Neurooncol"},{"key":"38_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1023\/B:NEON.0000021827.85754.8e","volume":"67","author":"D Loven","year":"2004","unstructured":"Loven D, Hardoff R, Sever ZB, et al.: Nonresectable slowgrowing meningiomas treated by hydroxyurea. J Neurooncol 2004, 67:221\u2013226.","journal-title":"J Neurooncol"},{"key":"38_CR17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3171\/jns.1997.86.5.0840","volume":"86","author":"UM Schrell","year":"1997","unstructured":"Schrell UM, Rittig MG, Anders M, et al.: Hydroxyurea for treatment of unresectable and recurrent meningiomas II: decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 1997, 86:840\u2013844.","journal-title":"J Neurosurg"},{"key":"38_CR18","unstructured":"Swinnen LJ, Barger GR, and Rushing EJ: Phase II study of hydroxyurea for unresectable meningioma. SWOG 2004."},{"key":"38_CR19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3171\/jns.1996.84.5.0733","volume":"84","author":"MC Chamberlain","year":"1996","unstructured":"Chamberlain MC: Adjuvant combined modality therapy for malignant meningiomas. J Neurosurg 1996, 84:733\u2013736.","journal-title":"J Neurosurg"},{"key":"38_CR20","first-page":"1","volume":"19","author":"JW Yarbro","year":"1992","unstructured":"Yarbro JW: Mechanism of action of hydroxyurea. Semin Oncol 1992, 19:1\u201310.","journal-title":"Semin Oncol"},{"key":"38_CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/jns.1994.80.2.0195","volume":"80","author":"BJ Goldsmith","year":"1994","unstructured":"Goldsmith BJ, Wara WM, Wilson CB, et al.: Postoperative irradiation for subtotally resected meningiomas: a retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994, 80:195\u2013201. Modern series establishing a dose response for fractionated radiation therapy in the treatment of meningioma.","journal-title":"J Neurosurg"},{"key":"38_CR22","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0360-3016(95)02166-3","volume":"34","author":"MF Milosevic","year":"1996","unstructured":"Milosevic MF, Frost PJ, Laperriere NJ, et al.: Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 1996, 34:817\u2013822. Excellent companion paper to the preceding reference.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0360-3016(97)00317-9","volume":"39","author":"KS Condra","year":"1997","unstructured":"Condra KS, Buatti JM, Mendenhall WM, et al.: Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys 1997, 39:427\u2013436.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1227\/01.NEU.0000079506.75164.F4","volume":"53","author":"NS Margalit","year":"2003","unstructured":"Margalit NS, Lesser JB, Moche J, et al.: Meningiomas involving the optic nerve: technical aspects and outcomes for a series of 50 patients. Neurosurgery 2003, 53:523\u2013532.","journal-title":"Neurosurgery"},{"key":"38_CR25","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2001.19.15.3547","volume":"19","author":"J Debus","year":"2001","unstructured":"Debus J, Wuendrich M, Pirzkall A, et al.: High efficacy of fractionated stereotactic radiotherapy of large baseof-skull meningiomas: long-term results. J Clin Oncol 2001, 19:3547\u20133553.","journal-title":"J Clin Oncol"},{"key":"38_CR26","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cncr.11645","volume":"98","author":"WM Mendenhall","year":"2003","unstructured":"Mendenhall WM, Morris CG, Amdur RJ, et al.: Radiotherapy alone or after subtotal resection for benign skull base meningiomas. Cancer 2003, 98:1473\u20131482.","journal-title":"Cancer"},{"key":"38_CR27","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0360-3016(90)90394-Y","volume":"18","author":"J Glaholm","year":"1990","unstructured":"Glaholm J, Bloom HJ, Crow JH: The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 1990, 18:755\u2013761.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.radonc.2004.04.008","volume":"72","author":"BG Baumert","year":"2004","unstructured":"Baumert BG, Villa S, Studer G, et al.: Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma. Radiother Oncol 2004, 72:169\u2013174.","journal-title":"Radiother Oncol"},{"key":"38_CR29","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0161-6420(02)01017-5","volume":"109","author":"RE Turbin","year":"2002","unstructured":"Turbin RE, Thompson CR, Kennerdell JS, et al.: A longterm visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology 2002, 109:890\u2013899.","journal-title":"Ophthalmology"},{"key":"38_CR30","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/bjo.86.11.1265","volume":"86","author":"S Pitz","year":"2002","unstructured":"Pitz S, Becker G, Schiefer U, et al.: Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol 2002, 86:1265\u20131268.","journal-title":"Br J Ophthalmol"},{"key":"38_CR31","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0360-3016(02)03753-7","volume":"54","author":"G Becker","year":"2002","unstructured":"Becker G, Jeremic B, Pitz S, et al.: Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 2002, 54:1422\u20131429.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0360-3016(03)00005-1","volume":"56","author":"S Narayan","year":"2003","unstructured":"Narayan S, Cornblath WT, Sandler HM, et al.: Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 2003, 56:537\u2013543.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR33","volume-title":"Intensity-Modulated Radiation Therapy (IMRT): A Clinical Perspective","author":"VW Stieber","year":"2005","unstructured":"Stieber VW, Munley M: Central nervous system tumors. In Intensity-Modulated Radiation Therapy (IMRT): A Clinical Perspective, edn 1. Edited by Mundt AJ, Roeske JC. Ontario: BC, Decker, Inc., 2005. Comprehensive analysis of the usefulness of IMRT in the treatment of central nervous system tumors.","edition":"edn 1."},{"key":"38_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0360-3016(98)00206-5","volume":"42","author":"RM Cardinale","year":"1998","unstructured":"Cardinale RM, Benedict SH, Wu Q, et al.: A comparison of three stereotactic radiotherapy techniques; ARCS versus noncoplanar fixed fields versus intensity modulation. Int J Radiat Oncol Biol Phys 1998, 42:431\u2013436.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1259\/bjr.75.892.750356","volume":"75","author":"A Zabel","year":"2002","unstructured":"Zabel A, Thilmann C, Zuna I, et al.: Comparison of forward planned conformal radiation therapy and inverse planned intensity modulated radiation therapy for esthesioneuroblastoma. Br J Radiol 2002, 75:356\u2013361.","journal-title":"Br J Radiol"},{"key":"38_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0958-3947(98)00015-6","volume":"23","author":"W Grant","year":"1998","unstructured":"Grant W III, Cain RB: Intensity modulated conformal therapy for intracranial lesions. Med Dosim 1998, 23:237\u2013241.","journal-title":"Med Dosim"},{"key":"38_CR37","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0360-3016(03)00587-X","volume":"57","author":"BG Baumert","year":"2003","unstructured":"Baumert BG, Norton IA, Davis JB: Intensity-modulated stereotactic radiotherapy versus stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base. Int J Radiat Oncol Biol Phys 2003, 57:580\u2013592.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR38","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0360-3016(02)03809-9","volume":"55","author":"A Pirzkall","year":"2003","unstructured":"Pirzkall A, Debus J, Haering P, et al.: Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience. Int J Radiat Oncol Biol Phys 2003, 55:362\u2013372.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-8140(03)00117-8","volume":"68","author":"A Bolsi","year":"2003","unstructured":"Bolsi A, Fogliata A, Cozzi L: Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study. Radiother Oncol 2003, 68:1\u201314.","journal-title":"Radiother Oncol"},{"key":"38_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0360-3016(99)00213-8","volume":"45","author":"VS Khoo","year":"1999","unstructured":"Khoo VS, Oldham M, Adams EJ, et al.: Comparison of intensity-modulated tomotherapy with stereotactically guided conformal radiotherapy for brain tumors. Int J Radiat Oncol Biol Phys 1999, 45:415\u2013425.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0958-3947(02)00097-3","volume":"27","author":"M Fuss","year":"2002","unstructured":"Fuss M, Salter BJ, Sadeghi A, et al.: Fractionated stereotactic intensity-modulated radiotherapy (FS-IMRT) for small acoustic neuromas. Med.Dosim 2002, 27:147\u2013154.","journal-title":"Med.Dosim"},{"key":"38_CR42","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0360-3016(01)02641-4","volume":"52","author":"E Huang","year":"2002","unstructured":"Huang E, Teh BS, Strother DR, et al.: Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 2002, 52:599\u2013605.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/jjco\/hyg053","volume":"33","author":"M Suzuki","year":"2003","unstructured":"Suzuki M, Nakamatsu K, Kanamori S, et al.: Feasibility study of the simultaneous integrated boost (SIB) method for malignant gliomas using intensity-modulated radiotherapy. Jpn J Clin Oncol 2003, 33:271\u2013277.","journal-title":"Jpn J Clin Oncol"},{"key":"38_CR44","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/00000421-200212000-00017","volume":"25","author":"G Voynov","year":"2003","unstructured":"Voynov G, Kaufman S, Hong T, et al.: Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 2003, 25:606\u2013611.","journal-title":"Am J Clin Oncol"},{"key":"38_CR45","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1200\/JCO.2002.09.126","volume":"20","author":"E Shaw","year":"2002","unstructured":"Shaw E, Arusell R, Scheithauer B, et al.: Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a North Central Cancer Treatment Group\/Radiation Therapy Oncology Group\/ Eastern Cooperative Oncology Group Study. J Clin Oncol 2002, 20:2267\u20132276.","journal-title":"J Clin Oncol"},{"key":"38_CR46","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0360-3016(02)02823-7","volume":"53","author":"NW Uy","year":"2002","unstructured":"Uy NW, Woo SY, Teh BS, et al.: Intensity-modulated radiation therapy (IMRT) for meningioma. Int J Radiat Oncol Biol Phys 2002, 53:1265\u20131270.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR47","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0360-3016(03)00126-3","volume":"56","author":"JC Flickinger","year":"2003","unstructured":"Flickinger JC, Kondziolka D, Maitz AH, et al.: Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma. Int J Radiat Oncol Biol Phys 2003, 56:801\u2013806.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR48","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/00006123-200111000-00001","volume":"49","author":"SL Stafford","year":"2001","unstructured":"Stafford SL, Pollock BE, Foote RL, et al.: Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001, 49:1029\u20131037. Large, well-analyzed series of meningiomas treated with radiosurgery.","journal-title":"Neurosurgery"},{"key":"38_CR49","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0360-3016(02)04356-0","volume":"55","author":"BE Pollock","year":"2003","unstructured":"Pollock BE, Stafford SL, Utter A, et al.: Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small-to medium-size meningiomas. Int J Radiat Oncol Biol Phys 2003, 55:1000\u20131005.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3171\/jns.2001.95.3.0435","volume":"95","author":"M Shin","year":"2001","unstructured":"Shin M, Kurita H, Sasaki T, et al.: Analysis of treatment outcome after stereotactic radiosurgery for cavernous sinus meningiomas. J Neurosurg 2001, 95:435\u2013439.","journal-title":"J Neurosurg"},{"key":"38_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1023\/B:NEON.0000013500.11150.36","volume":"66","author":"CC Chuang","year":"2004","unstructured":"Chuang CC, Chang CN, Tsang NM, et al.: Linear accelerator-based radiosurgery in the management of skull-base meningiomas. J Neurooncol 2004, 66:241\u2013249.","journal-title":"J Neurooncol"},{"key":"38_CR52","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00006123-199803000-00001","volume":"42","author":"BR Subach","year":"1998","unstructured":"Subach BR, Lunsford LD, Kondziolka D, et al.: Management of petroclival meningiomas by stereotactic radiosurgery. Neurosurgery 1998, 42:437\u2013443.","journal-title":"Neurosurgery"},{"key":"38_CR53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3171\/jns.2002.97.1.0065","volume":"97","author":"JY Lee","year":"2002","unstructured":"Lee JY, Niranjan A, McInerney J, et al.: Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 2002, 97:65\u201372.","journal-title":"J Neurosurg"},{"key":"38_CR54","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0360-3016(02)02802-X","volume":"53","author":"A Nicolato","year":"2002","unstructured":"Nicolato A, Foroni R, Alessandrini F, et al.: The role of gamma knife radiosurgery in the management of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 2002, 53:992\u20131000.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR55","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1227\/01.NEU.0000047814.18819.9F","volume":"52","author":"Y Iwai","year":"2003","unstructured":"Iwai Y, Yamanaka K, Ishiguro T: Gamma knife radiosurgery for the treatment of cavernous sinus meningiomas. Neurosurgery 2003, 52:517\u2013524.","journal-title":"Neurosurgery"},{"issue":"Suppl","key":"38_CR56","first-page":"71","volume":"84","author":"S Eustacchio","year":"2002","unstructured":"Eustacchio S, Trummer M, Fuchs I, et al.: Preservation of cranial nerve function following Gamma Knife radiosurgery for benign skull base meningiomas: experience in 121 patients with follow-up of 5 to 9.8 years. Acta Neurochir 2002, 84(Suppl):71\u201376.","journal-title":"Acta Neurochir"},{"key":"38_CR57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3171\/jns.1998.88.1.0043","volume":"88","author":"KA Leber","year":"1998","unstructured":"Leber KA, Bergloff J, Pendl G: Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998, 88:43\u201350.","journal-title":"J Neurosurg"},{"key":"38_CR58","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0360-3016(02)04380-8","volume":"55","author":"SL Stafford","year":"2003","unstructured":"Stafford SL, Pollock BE, Leavitt JA, et al.: A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2003, 55:1177\u20131181. Well-done analysis of vision preservation after radiosurgery.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"38_CR59","volume-title":"Principles and Practice of Radiation Oncology","author":"VW Stieber","year":"2003","unstructured":"Stieber VW, de Guzman AF: Pituitary. In Principles and Practice of Radiation Oncology. Edited by Perez C, Brady L, Schmidt-Ullrich R, et al. New York: Lippincott Williams & Wilkins, 2003."},{"key":"38_CR60","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/00006123-199809000-00001","volume":"43","author":"D Kondziolka","year":"1998","unstructured":"Kondziolka D, Flickinger JC, Perez B: Judicious resection and\/or radiosurgery for parasagittal meningiomas: outcomes from a multicenter review Gamma Knife Meningioma Study Group. Neurosurgery 1998, 43:405\u2013413.","journal-title":"Neurosurgery"},{"key":"38_CR61","doi-asserted-by":"publisher","first-page":"936","DOI":"10.4065\/73.10.936","volume":"73","author":"SL Stafford","year":"1998","unstructured":"Stafford SL, Perry A, Suman VJ, et al.: Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 1998, 73:936\u2013942. Seminal reference on the prognostic factors of meningiomas.","journal-title":"Mayo Clin Proc"},{"key":"38_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0090-3019(01)00479-7","volume":"56","author":"F Roberti","year":"2001","unstructured":"Roberti F, Sekhar LN, Kalavakonda C, et al.: Posterior fossa meningiomas: surgical experience in 161 cases. Surg Neurol 2001, 56:8\u201320.","journal-title":"Surg Neurol"},{"key":"38_CR63","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00041327-199809000-00013","volume":"18","author":"SL Stafford","year":"1998","unstructured":"Stafford SL, Perry A, Leavitt JA, et al.: Anterior visual pathway meningiomas primarily resected between 1978 and 1988: the Mayo Clinic Rochester experience. J Neuroophthalmol 1998, 18:206\u2013210. Describes the role of surgery in the treatment of optic pathway meningiomas.","journal-title":"J Neuroophthalmol"},{"key":"38_CR64","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/cncr.20058","volume":"100","author":"FG Barker","year":"2004","unstructured":"Barker FG: Craniotomy for the resection of metastatic brain tumors in the United States, 1988\u20132000: decreasing mortality and the effect of provider caseload. Cancer 2004, 100:999\u20131007.","journal-title":"Cancer"},{"key":"38_CR65","first-page":"2269","volume":"7","author":"C Muhr","year":"2001","unstructured":"Muhr C, Gudjonsson O, Lilja A, et al.: Meningioma treated with interferon-alpha, evaluated with [(11)C]-L-methionine positron emission tomography. Clin Cancer Res 2001, 7:2269\u20132276.","journal-title":"Clin Cancer Res"},{"key":"38_CR66","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00006123-199702000-00007","volume":"40","author":"SE Kaba","year":"1997","unstructured":"Kaba SE, DeMonte F, Bruner JM, et al.: The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery 1997, 40:271\u2013275.","journal-title":"Neurosurgery"},{"key":"38_CR67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4615-3876-9_8","volume":"58","author":"SM Grunberg","year":"1991","unstructured":"Grunberg SM: The role of progesterone receptors in meningioma. Cancer Treat Res 1991, 58:127\u2013137.","journal-title":"Cancer Treat Res"},{"key":"38_CR68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/jnnp.55.6.486","volume":"55","author":"SW Lamberts","year":"1992","unstructured":"Lamberts SW, Tanghe HL, Avezaat CJ, et al.: Mifepristone (RU 486) treatment of meningiomas. J Neurol Neurosurg Psychiatry 1992, 55:486\u2013490.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"38_CR69","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3171\/jns.2002.97.3.0668","volume":"97","author":"MD Johnson","year":"2002","unstructured":"Johnson MD, Okedli E, Woodard A, et al.: Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells. J Neurosurg 2002, 97:668\u2013675.","journal-title":"J Neurosurg"},{"key":"38_CR70","unstructured":"National Cancer Institute: Phase II Trial of STI571 (NSC716051) in patients with recurrent meningiomas. http:\/\/clinicalstudies.info.nih.gov\/cgi\/detail.cgi?A_03-C-0311.html. Accessed September 12, 2004."},{"key":"38_CR71","unstructured":"The North American Brain Tumor Consortium: Phase II Trial of STI571 in Patients with Recurrent Meningioma. http:\/\/www.nf.org\/clinical_trials\/nf2\/meningioma\/ STI571.htm. Accessed September 12, 2004."},{"key":"38_CR72","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/sj.bjc.6601550","volume":"90","author":"G Blackledge","year":"2004","unstructured":"Blackledge G, Averbuch S: Gefitinib (\u2018Iressa\u2019, ZD1839) and new epidermal growth factor receptor inhibitors. Br J Cancer 2004, 90:566\u2013572.","journal-title":"Br J Cancer"},{"key":"38_CR73","first-page":"427","volume":"24","author":"YG Kong","year":"2002","unstructured":"Kong YG, Su CB, Ren ZY, et al.: Measurement of epidermal growth factor receptor concentration in the pre-and postoperative serum in patients with meningiomas. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002, 24:427\u2013429.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"38_CR74","unstructured":"National Cancer Institute: ZD1839 for Treatment of Recurrent or Progressive Malignant Astrocytoma or Glioblastoma and Recurrent or Progressive Meningioma: A Phase II Study with a Phase I Component for Patients Receiving enzyme-inducing antiepileptic drugs (EIAEDs). http:\/\/www.virtualtrials. com. Accessed September 12, 2004."},{"key":"38_CR75","unstructured":"National Cancer Institute: Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma. http:\/\/clinicaltrials. gov. Accessed September 12, 2004."},{"issue":"Suppl 3","key":"38_CR76","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1634\/theoncologist.8-suppl_3-30","volume":"8","author":"SM Sebti","year":"2003","unstructured":"Sebti SM: Blocked pathways: FTIs shut down oncogene signals. Oncologist 2003, 8(Suppl 3):30\u201338.","journal-title":"Oncologist"},{"key":"38_CR77","unstructured":"National Cancer Institute: Pediatric Brain Tumor Consortium. SCH 66336 in treating children with recurrent or progressive brain tumors. Accessible at http:\/\/clinicaltrials.gov\/ct\/show\/ NCT00015899?order=12. Accessed September 12, 2004."},{"key":"38_CR78","first-page":"4263","volume":"62","author":"PA Burke","year":"2002","unstructured":"Burke PA, DeNardo SJ, Miers LA, et al.: Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts. Cancer Res 2002, 62:4263\u20134272.","journal-title":"Cancer Res"},{"key":"38_CR79","unstructured":"National Cancer Institute: Phase I Trial and Pharmacokinetic Study of ABT-751, An Orally Bioavailable Tubulin Binding Agent, on a 7 Day and 21 Day Dosing Schedule in Pediatric Patients With Refractory Solid Tumors. Accessible at http:\/\/clinicalstudies. info.nih.gov\/detail\/A_2002-C-0141.html. Accessed September 12, 2004."}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-004-0038-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0038-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-004-0038-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T13:14:21Z","timestamp":1652620461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-004-0038-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s11864-004-0038-y","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}